Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Study finds cells which contribute to equine tendon injuries
“The findings of these experiments will allow future studies to develop therapeutics for tendon injuries targeted at specific cell populations” – Dr Chavaunne Thorpe.
The research could pave the way for new treatments.

Scientists have identified the different cell populations in horses’ tendons and determined which cells are disproportionately affected by ageing.

Although it is well known that the risk of tendon injuries increases with age in horses, this is the first study to discover the particular cells which are most affected by ageing. It is hoped that the work will pave the way for researchers to develop tendon-injury treatments which target these cells.

Led by Dr Chavaunne Thorpe of the Royal Veterinary College, the researchers used single cell RNA sequencing to identify the different cell types in superficial digital flexor tendons from both young and old horses.

The researchers identified a total of 11 cell types, including cells associated with blood vessels and the immune system as well as several different populations of tenocytes. They found that one tenocyte population and one blood-vessel-associated population associated were most affected by ageing, with an altered ability to maintain tendon structure and respond to injury.

Dr Thorpe said: “Our results uncover just how complex and variable cell populations within tendons are and show that some cells are particularly prone to age-related alterations, helping to explain why the risk of tendon injury is higher in older individuals.

“The findings of these experiments will allow future studies to develop therapeutics for tendon injuries targeted at specific cell populations.”

Dr Danae Zamboulis, one of the contributors to the study, added: “This study is an exciting step towards understanding the cells that regulate tendon function and injury.”

The study has been published in the journal Aging and Disease.

Become a member or log in to add this story to your CPD history

Strangles survey seeks views of horse owners

News Story 1
 With Strangles Awareness Week just around the corner (5-11 May), vets are being encouraged to share a survey about the disease with their horse-owning clients.

The survey, which has been designed by Dechra, aims to raise awareness of Strangles and promote best practices to prevent its transmission. It includes questions about horse owners' experiences of strangles, together with preventative measures and vaccination.

Respondents to the survey will be entered into a prize draw to win two VIP tickets to Your Horse Live 2025. To access the survey, click here 

Click here for more...
News Shorts
DAERA to reduce BVD 'grace period'

DAERA has reminded herd keepers of an upcoming reduction to the 'grace period' to avoid BVD herd restrictions.

From 1 May 2025, herd keepers will have seven days to cull any BVD positive or inconclusive animals to avoid restrictions being applied to their herd.

It follows legislation introduced on 1 February, as DAERA introduces herd movement restrictions through a phased approach. Herd keepers originally had 28 days to cull BVD positive or inconclusive animals.

DAERA says that, providing herd keepers use the seven-day grace period, no herds should be restricted within the first year of these measures.

Additional measures, which will target herds with animals over 30 days old that haven't been tested for BVD, will be introduced from 1 June 2025.

More information is available on the DAERA website.